日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

一项 Ib 期首次人体研究,旨在评估 Ponsegromab 在癌症合并恶病质患者中的安全性、耐受性、药代动力学和药效学。

Crawford, Jeffrey; Calle, Roberto A; Collins, Susie M; Weng, Yan; Lubaczewski, Shannon L; Buckeridge, Clare; Wang, Ellen Q; Harrington, Magdalena A; Tarachandani, Anil; Rossulek, Michelle I; Revkin, James H

Mortality burden of pre-treatment weight loss in patients with non-small-cell lung cancer: A systematic literature review and meta-analysis

非小细胞肺癌患者治疗前体重减轻的死亡负担:系统文献综述和荟萃分析

Bonomi, Philip D; Crawford, Jeffrey; Dunne, Richard F; Roeland, Eric J; Smoyer, Karen E; Siddiqui, Mohd Kashif; McRae, Thomas D; Rossulek, Michelle I; Revkin, James H; Tarasenko, Lisa C

The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review

结直肠癌或胰腺癌患者恶病质或体重减轻的死亡负担:系统性文献综述

Dunne, Richard F; Crawford, Jeffrey; Smoyer, Karen E; McRae, Thomas D; Rossulek, Michelle I; Revkin, James H; Tarasenko, Lisa C; Bonomi, Philip D

Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design

一项评估ponsegromab治疗癌症恶病质患者疗效和安全性的II期研究:PROACC-1研究设计

Groarke, John D; Crawford, Jeffrey; Collins, Susie M; Lubaczewski, Shannon L; Breen, Danna M; Harrington, Magdalena A; Jacobs, Ira; Qiu, Ruolun; Revkin, James; Rossulek, Michelle I; Saxena, Aditi R

Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: A systematic literature review

生长分化因子-15与心力衰竭患者不良预后之间的关联:一项系统性文献综述

Javaheri, Ali; Ozcan, Mualla; Moubarak, Lauren; Smoyer, Karen E; Rossulek, Michelle I; Revkin, James H; Groarke, John D; Tarasenko, Lisa C; Kosiborod, Mikhail N

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

对一种用于治疗 COVID-19 的静脉注射冠状病毒 3CL 蛋白酶抑制剂进行临床前表征

Britton Boras # ,Rhys M Jones # ,Brandon J Anson ,Dan Arenson ,Lisa Aschenbrenner ,Malina A Bakowski ,Nathan Beutler ,Joseph Binder ,Emily Chen ,Heather Eng ,Holly Hammond ,Jennifer Hammond ,Robert E Haupt ,Robert Hoffman ,Eugene P Kadar ,Rob Kania ,Emi Kimoto ,Melanie G Kirkpatrick ,Lorraine Lanyon ,Emma K Lendy ,Jonathan R Lillis ,James Logue ,Suman A Luthra ,Chunlong Ma ,Stephen W Mason ,Marisa E McGrath ,Stephen Noell ,R Scott Obach ,Matthew N O' Brien ,Rebecca O'Connor ,Kevin Ogilvie ,Dafydd Owen ,Martin Pettersson ,Matthew R Reese ,Thomas F Rogers ,Romel Rosales ,Michelle I Rossulek ,Jean G Sathish ,Norimitsu Shirai ,Claire Steppan ,Martyn Ticehurst ,Lawrence W Updyke ,Stuart Weston ,Yuao Zhu ,Kris M White ,Adolfo García-Sastre ,Jun Wang ,Arnab K Chatterjee ,Andrew D Mesecar ,Matthew B Frieman ,Annaliesa S Anderson ,Charlotte Allerton

Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study

PF-05231023(一种新型长效FGF21模拟物)在首次人体试验中的药代动力学和药效学研究

Dong, Jennifer Q; Rossulek, Michelle; Somayaji, Veena R; Baltrukonis, Daniel; Liang, Yali; Hudson, Krischan; Hernandez-Illas, Martha; Calle, Roberto A